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388Objective: The use of pledgeted sutures to secure the prosthetic valve to the annulus during aortic valve replace-
ment is thought to decrease the incidence of paravalvular leak. We hypothesized that use of nonpledgeted sutures
in aortic valve replacement would provide equivalent outcomes to those of a pledgeted suture technique.
Methods: Between January 1995 and April 2009, a total of 802 patients (511 nonpledgeted, 291 pledgeted)
underwent isolated aortic valve replacement, including 671 patients who underwent primary, isolated aortic valve
replacement (412 nonpledgeted, 259 pledgeted). Preoperative risk, intraoperative findings, and postoperative
complications, including operative mortality, were evaluated.
Results:Operative mortalities in isolated AVR operations were similar at 2.5% and 3.1% (P>.66) for nonpledg-
eted and pledgeted groups, respectively. Paravalvular leak rates after aortic valve replacement were equivalent in
nonpledgeted and pledgeted groups (0.8% vs 1.4%, respectively, P ¼ .47). Reoperation for paravalvular leak
was rare in both groups. Importantly, the nonpledgeted technique incurred significantly shorter aortic crossclamp
time (58.1 0.3 minutes vs 61.6 0.4 minutes, P<.001) and cardiopulmonary bypass time (87.5 0.8 minutes
vs 90.3  0.8 minutes, P ¼ .02) than did the pledgeted technique.
Conclusions: A nonpledgeted suture technique offers an equivalent alternative to the traditional use of pledgets
during aortic valve replacement, with no increase in paravalvular leak rate. This nonpledgeted suture technique
provides a time efficient and safe approach to aortic valve replacement operations. (J Thorac Cardiovasc Surg
2011;141:388-93)Aortic valve disease is a common condition with advancing
age, and aortic stenosis is the most common valve condition
for which aortic valve replacement (AVR) is performed
within the United States. According to the Society for
Thoracic Surgeons (STS), approximately 12,000 to 18,000
isolated AVR operations are performed annually, with oper-
ative mortalities approaching 3%.1 Current demographic
trends indicate a significant increase in the US geriatric pop-
ulation, resulting from the rising ‘‘baby boomer’’ population
coupled with the increase in human life span. Clinically
significant calcific aortic stenosis requiring AVR is common
within this population, occurring in approximately 20% of
patients.2 Consequently, evaluation of current approaches to
operative management of aortic valve disease is justified.
Major paravalvular leak after AVR is a serious complica-
tion and a significant risk, and the classic surgical approach
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The Journal of Thoracic and Cardiovascular Surgpledgeted, nonabsorbable sutures to secure the prosthesis
to the aortic annulus. Clinically significant paravalvular
leak necessitating reoperation has been reported to occur
in fewer than 2% of cases.3 Within the United States, the
use of pledgets during AVR is common. Pledgeted sutures
to the secure the valve prosthesis to the valve annulus during
mitral, aortic, and double mechanical valve replacements
have been shown to have a protective effect against postop-
erative paravalvular leak in comparisons with several differ-
ent suture techniques.4 To our knowledge, however, the
effect of a uniform, nonpledgeted suture technique during
AVR has not been previously well established.
At our institution, we have adopted the routine use of non-
pledgeted sutures during AVR because we believe this ap-
proach to be efficient and yet carry minimal risk of major
paravalvular leak. Accordingly, in this study, we sought to
evaluate the use of a nonpledgeted suture technique during
AVR. We hypothesized that a nonpledgeted AVR technique
would be equivalent to a pledgeted technique with respect to
operative mortality, major paravalvular leak rate, and need
for subsequent aortic valve reoperation.
MATERIALS AND METHODS
Patients
This studywas approvedby the human investigation committee of theUni-
versity of Virginia Health System (HSR 14064). All AVR operations at our
institutionwere entered prospectively into the STSNationalDatabase.We ret-
rospectively reviewed all patients undergoing isolated AVR from January
1995 to April 2009. Primary AVRs were defined as those occurring in theery c February 2011
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
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according to suture technique into nonpledgeted and pledgeted AVR groups.
In subgroup analysis, we further studied patients undergoing primary, isolated
AVR to eliminate the confounding effects of reoperation on outcomes.
Patient characteristics, risk factors, operative features, and postoperative
outcomes were evaluated. We used known STS definitions to describe all
preoperative and operative variables as well as postoperative outcomes.
Operative mortality included patient deaths occurring before hospital
discharge or within 30 days after the operation. Incidence of major paravalv-
ular leak was evaluated immediately after AVR with transesophageal echo-
cardiography, and transthoracic echocardiography was used to detect major
paravalvular leak during postoperative follow-up.
Operative Technique
Standard AVR procedures were used in all cases. A complete median ster-
notomy was performed. Intraoperative transesophageal echocardiography
was routinely used to assess the diseased aortic valve before sternotomy.After
cardiopulmonary bypass was established and the aortic crossclamp placed,
cardioplegia was administered into the aortic root through a retrograde coro-
nary sinus catheter. A transverse aortotomy was made 2 to 3 cm distal to the
origin of the right coronary artery, the diseased aortic valve was visualized,
and the valve leaflets were carefully excised, including de´bridement of all cal-
cific deposits within the aortic annulus. The valve prosthesis was sized, se-
lected, and sewn to the aortic annulus with 12 to 18 sutures. In the
pledgeted group, 2-0 Ti-Cron sutures (Covidien, Mansfield, Mass) with pre-
madepledgetswereplaced in a horizontalmattress fashion, placing the sutures
from the ventricular side of the annulus to the aortic side of the annulus. In the
nonpledgeted group, 2-0 Ti-Cron sutures without pledgets were placed in
a similar fashion. With both techniques, the sutures were then passed through
the sewing ring of the prosthetic valve, and the valve was secured in a supra-
annular position. No continuous or simple, interrupted sutures were used. The
aortotomy was closed with running nonabsorbable polypropylene suture in 2
layers. Deairing was performed, and the aortic crossclamp was then removed.
During the deairing process, transesophageal echocardiography was used to
verify adequate deairing and to assess the newly implanted prosthesis for com-
petence and the presence of paravalvular leak. The patient was then weaned
from cardiopulmonary bypass, pacing wires and drainage tubes were placed,
and the wound was closed in the standard surgical fashion.
Statistical Analysis
Our primary outcomes of interest were operative mortality, major para-
valvular leak rate, and need for aortic valve reoperation for major paravalv-
ular leak among all patients undergoing nonpledgeted versus pledgeted
AVR. All group comparisons were unpaired. Bivariate comparisons with ei-
ther Pearson c2 or Fisher’s Exact tests were used for all categoric variables.
Analysis of variance was used for all continuous variables.
Categoric variable comparisons are expressed as percentages of each
group of origin. Continuous variables are reported as mean  SEM. Re-
portedP values are 2-tailed. Data manipulation and analysis were performed
with SPSS software (version 17; SPSS Inc, an IBMCompany, Chicago, Ill).
RESULTS
Comparison of Patient Characteristics and
Operative Features
A total of 802 patients (511 nonpledgeted vs 291 pledg-
eted) underwent isolated AVR operations from JanuaryThe Journal of Thoracic and Ca1995 to April 2009 (Table 1). The average patient age was
higher among patients undergoing nonpledgeted AVR
(67.0  0.7 years) than those undergoing pledgeted AVR
(62.7 1.5 years, P¼ .01). Previous coronary artery bypass
grafting operations had been performed in 13.3% and 4.5%
(P< .001) of nonpledgeted and pledgeted patient groups,
respectively. The prevalences of previous valve operations
were similar. Infective endocarditis incidences were similar
between nonpledgeted and pledgeted AVR groups. Patients
undergoing isolated, pledgeted AVR had statistically lower
preoperative ejection fractions (51.8%) than did those un-
dergoing isolated, nonpledgeted AVR (53.6%, P ¼ .03).
Aortic crossclamp time (58.1  0.3 minutes vs 61.6  0.4
minutes, P < .001) and cardiopulmonary bypass time
(87.5  0.8 minutes vs 90.3  0.8 minutes, P ¼ .02) were
shorter in the nonpledgeted AVR group than in the pledg-
eted AVR group.
Similar trends in patient demographic characteristics, risk
factors, and operative features were observed among pa-
tients undergoing primary, isolated AVR (Table 2). A total
of 671 patients (412 nonpledgeted vs 259 pledgeted) under-
went primary, isolated AVR. The nonpledgeted AVR group
was older (P¼ .004), with higher rates of preoperative cere-
brovascular disease (P ¼ .04), dyslipidemia (P< .001), and
hypertension (P< .001). Intraoperatively, the nonpledgeted
group had shorter aortic crossclamp time (57.8  0.3 vs
61.6  0.5 minutes, P< .001) and cardiopulmonary bypass
time (84.7  0.6 vs 89.5  0.8 minutes, P< .001) than did
the pledgeted group. Urgent and emergency operations were
more common among patients undergoing primary, isolated
nonpledgeted AVR.
Comparison of Early and Late Outcomes
An analysis of outcomes of all patients undergoing isolated
AVR revealed no significant differences between nonpledg-
eted and pledgeted groups (Table 3). Operative mortalities
were similarly low in both AVR operative groups. Paravalvu-
lar leaks and the need for reoperation were similarly rare.
Mean patient follow-up was 82.0  1.9 months. Eight cases
of major paravalvular leak occurred at 51.3  16.7 months
after either nonpledgeted or pledgeted AVR. Patient charac-
teristics and operative features for patients incurring major
paravalvular leaks appear in Table 4. Among patients under-
going primary, isolated AVR (Table 5), operative mortalities
were similar (1.9% vs 2.3%, P ¼ .79) in the nonpledgeted
and pledgeted AVR groups. Moreover, paravalvular leaks
after primary, isolated AVR (P ¼ .38) and the need for reop-
eration for paravalvular leak (P ¼ .06) were both uncommon
and comparable between groups. Total hospital of stay was
longer among patients undergoing primary, isolated pledgeted
AVR (P¼ .02). None of the patients with a preoperative his-
tory of endocarditis incurred a major paravalvular leak after
AVR. All other measured postoperative outcomes were simi-
lar regardless of nonpledgeted or pledgeted AVR technique.rdiovascular Surgery c Volume 141, Number 2 389
TABLE 1. Preoperative and operative variables for patients undergoing isolated aortic valve replacement with a nonpledgeted versus pledgeted
suture technique (n ¼ 802)
Variable Nonpledgeted (n ¼ 511) Pledgeted (n ¼ 291) P value
Preoperative
Age (y, mean  SEM) 67.0  0.7 62.7  1.5 .01
Sex (no. female) 200 (39.1%) 122 (41.9%) .45
Hypertension (no.) 363 (71.0%) 146 (50.2%) >.001
Peripheral arterial disease (no.) 49 (9.6%) 19 (6.5%) .15
Stroke (no.) 39 (7.6%) 10 (3.4%) .02
Diabetes mellitus (no.) 104 (20.4%) 47 (16.2%) .16
Dyslipidemia (no.) 310 (60.7%) 83 (28.5%) >.001
Atrial fibrillation (no.) 93 (18.2%) 32 (11.0%) .01
Heart block (no.) 11 (2.2%) 8 (2.7%) .63
Ventricular tachycardia (no.) 1 (0.2%) 2 (0.7%) .30
New York Heart Association functional class (no.)
I 235 (46.0%) 146 (49.0%) .43
II 93 (18.2%) 62 (20.8%) .40
III 119 (23.3%) 58 (19.5%) .22
IV 64 (12.5%) 32 (10.7%) .50
Heart failure (no.) 191 (37.4%) 109 (37.5%) >.99
Infective endocarditis (no.) 34 (6.7%) 17 (5.8%) .76
Renal failure (no.) 42 (8.2%) 24 (8.2%) >.99
Hemodialysis (no.) 10 (2.0%) 7 (2.4%) .80
Ejection fraction (%, mean  SEM) 53.6  0.5 51.8  0.6 .03
Previous coronary artery bypass grafting (no.) 68 (13.3%) 13 (4.5%) >.001
Previous valve operation (no.) 42 (8.2%) 20 (6.9%) .58
Aortic insufficiency (no.)
Moderate 57 (11.2%) 52 (17.9%) .01
Severe 92 (18.0%) 48 (16.5%) .63
Aortic stenosis (no.) 427 (83.6%) 216 (74.2%) .004
Operative
Urgency (no.)
Elective 386 (75.5%) 232 (79.7%) .19
Urgent 119 (23.3%) 58 (19.9%) .29
Emergency 6 (1.2%) 1 (0.3%) .43
Prosthesis type (no.)
Bioprosthesis 431 (84.3%) 160 (55.0%) >.001
Mechanical prosthesis 77 (15.1%) 122 (41.9%) >.001
Homograft 3 (0.6%) 9 (3.1%) .01
Aortic crossclamp time (min, mean  SEM) 58.1  0.3 61.6  0.4 >.001
Cardiopulmonary bypass time (min, mean  SEM) 87.5  0.8 90.3  0.8 .02
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DDISCUSSION
In this study, we have corroborated current evidence to
suggest improved outcomes among open AVR operations,
and we have highlighted a time efficient and clinically
equivalent approach to AVR with a nonpledgeted suture
technique to secure the aortic valve prosthesis to the aortic
annulus. Our study groups were well matched with respect
to patient demographic characteristics and preoperative
risk factors. Trends in postoperative outcomes between
study groups were unchanged by the inclusion of reoperative
isolated AVR procedures. Most importantly, operative mor-
tality, major paravalvular leak rate, and need for reoperation
for major paravalvular leak were equivalent in nonpledgeted
and pledgeted AVR operations. Further, a nonpledgeted390 The Journal of Thoracic and Cardiovascular Surgtechnique allowed statistically shorter aortic crossclamp
and total cardiopulmonary bypass times. We believe that
this study provides important contributions to the examina-
tion of contemporary outcomes of open AVR operations.
Major paravalvular leak remains a serious complication
and primary concern after AVR. Small, clinically benign,
paravalvular leaks are common in the early postoperative
setting and are well tolerated.5 Larger, major paravalvular
leaks, however, occur after 1% to 5% of AVR procedures
and have greater clinical relevance. Such leaks have been
shown to be associated with heavy annular calcification.5-7
Although significant paravalvular leaks initially may be
managed medically, reoperative AVR is frequently
required for definitive management. Reoperation in turnery c February 2011
TABLE 2. Preoperative and operative variables for all patients undergoing primary, isolated AVR with a nonpledgeted versus pledgeted suture
technique (n ¼ 671)
Variable Nonpledgeted (n ¼ 412) Pledgeted (n ¼ 259) P value
Preoperative
Age (y, mean  SEM) 67.2  0.7 62.3  1.5 .994
Sex (no. female) 174 (42.2%) 115 (44.4%) .63
Hypertension (no.) 279 (67.7%) 126 (48.6%) >.001
Peripheral arterial disease (no.) 31 (7.5%) 15 (5.8%) .44
Stroke (no.) 28 (6.8%) 9 (3.5%) .08
Diabetes mellitus (no.) 76 (18.4%) 38 (14.7%) .25
Dyslipidemia (no.) 232 (56.3%) 66 (25.5%) >.001
Atrial fibrillation (no.) 70 (17.0%) 30 (11.6%) .06
Heart block (no.) 9 (2.2%) 6 (2.3%) >.99
Ventricular tachycardia (no.) 1 (0.2%) 1 (0.4%) >.99
New York Heart Association functional class (no.)
I 213 (51.7%) 123 (47.5%) .30
II 87 (21.1%) 58 (22.4%) .70
III 79 (19.2%) 55 (21.2%) .55
IV 33 (8.0%) 23 (8.9%) .77
Heart failure (no.) 155 (37.6%) 97 (37.5%) >.99
Infective endocarditis (no.) 18 (4.4%) 10 (3.9%) .84
Renal failure (no.) 33 (8.0%) 21 (8.1%) >.99
Hemodialysis (no.) 6 (1.5%) 6 (2.3%) .55
Ejection fraction (%, mean  SEM) 54.1  0.6 52.1  0.7 .02
Aortic insufficiency (no.)
Moderate 50 (12.1%) 45 (17.4%) .04
Severe 73 (17.7%) 44 (17.0%) .84
Aortic stenosis (no.) 349 (84.7%) 200 (77.2%) .02
Operative
Urgency (%)
Elective 311 (75.5%) 211 (81.5%) .07
Urgent 96 (23.3%) 47 (18.1%) .12
Emergency 5 (1.2%) 1 (0.4%) .41
Prosthesis type (no.)
Bioprosthesis 354 (85.9%) 143 (55.2%) >.001
Mechanical prosthesis 57 (13.8%) 109 (42.1%) >.001
Homograft 7 (1.7%) 5 (1.9%) >.99
Aortic crossclamp time (min, mean  SEM) 57.8  0.3 61.6  0.5 >.001
Cardiopulmonary bypass time (min, mean  SEM) 84.7  0.6 89.5  0.8 >.001
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leak.6,8
The use of pledgeted sutures has been suggested to
decrease the risk of paravalvular leak after AVR.4 In their
review of 807 patients undergoing mechanical heart valve
replacement with 6 different suture techniques, Englberger
and colleagues4 documented a 5.8% incidence of major par-
avalvular leak among patients undergoing mitral, aortic, and
double valve replacements with a nonpledgeted suture tech-
nique. Moreover, on multivariate modeling, this group dem-
onstrated that a nonpledgeted suture technique was an
independent risk factor for major paravalvular leak events.
Similarly, another study demonstrated that the use of small
monofilament suture in a continuous fashion increased the
risk of paravalvular leak relative to pledgeted sutures placed
in a horizontal mattress fashion during mitral valve replace-The Journal of Thoracic and Cament.9 In that study, a nonpledgeted, horizontal mattress su-
ture technique was not evaluated. Thus the effect of using
nonpledgeted, horizontal mattress sutures on the incidence
of major paravalvular leak exclusively after AVR has not
been well defined.
In this study, major paravalvular leaks after isolated AVR
were rare (<1.5%), despite the use of a nonpledgeted suture
technique, and the incidence of major paravalvular leak
among patients undergoing primary, isolated nonpledgeted
AVR was less than 1%. With a mean follow-up of 82
months, we found that major paravalvular leak was detected
at a mean of 51 months by routine transthoracic echocardi-
ography. These results demonstrate the efficacious use of
nonpledgeted sutures to secure a prosthetic valve to the
aortic valve annulus without any increased risk of paravalv-
ular leak relative to the use of a pledgeted suture technique.rdiovascular Surgery c Volume 141, Number 2 391
TABLE 3. Postoperative outcomes for patients undergoing isolated aortic valve replacement with a nonpledgeted versus pledgeted suture
technique (n ¼ 802)
Variable Nonpledgeted (n ¼ 511) Pledgeted (n ¼ 291) P value
Sepsis (no.) 8 (1.6%) 5 (1.7%) >.99
Stroke (no.) 12 (2.3%) 6 (2.1%) >.99
Perioperative myocardial infarction (no.) 2 (0.4%) 0 (0.0%) .54
Reoperation for bleeding or tamponade (no.) 13 (2.5%) 7 (2.4%) >.99
Atrial fibrillation (no.) 119 (23.3%) 82 (28.8%) .13
Heart block (no.) 11 (2.2%) 8 (2.7%) .63
Cardiac arrest (no.) 7 (1.4%) 7 (2.4%) .28
Gastrointestinal event (no.) 7 (1.4%) 7 (2.4%) .28
Pneumonia (no.) 19 (3.7%) 8 (2.7%) .55
Prolonged ventilation (no.) 39 (7.6%) 13 (4.5%) >.99
Renal failure (no.) 20 (3.9%) 18 (6.2%) .17
Hemodialysis (new onset, no.) 6 (1.2%) 0 (0.0%) .09
Hospital stay (d, mean  SEM)
Total 8.6  0.4 10.2  1.0 .11
Postoperative 7.3  0.4 7.4  0.8 .96
Paravalvular leak (no.) 4 (0.8%) 4 (1.4%) .47
Reoperation for paravalvular leak (no.) 1 (0.2%) 4 (1.4%) .06
Operative mortality (no.) 13 (2.5%) 9 (3.1%) .66
TABLE 5. Postoperative outcomes for patients undergoing primary,
isolated aortic valve replacement with a nonpledgeted versus
pledgeted suture technique (n ¼ 671)
Nonpledgeted Pledgeted P
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leak was extremely low, with only 1 patient (0.2%) under-
going reoperation after isolated nonpledgeted AVR. In our
experience, a nonpledgeted suture technique does not in-
crease the risk of reoperation after primary AVR.
Important patient characteristics among our study groups
warrant further discussion. The incidences of preoperative
infective endocarditis were similar in the groups and did
not affect the major paravalvular leak rate after either non-
pledgeted or pledgeted AVR. Patients undergoing AVR
with pledgets had a higher proportion of mechanical valve
implantation, whereas those undergoing nonpledgetedTABLE 4. Patient demographic characteristics, preoperative risk
factors, and operative features for patients incurring major
paravalvular leaks after isolated, nonpledgeted or pledgeted aortic
valve replacement (n ¼ 8)
Variable
Nonpledgeted
(n ¼ 4)
Pledgeted
(n ¼ 4)
Demographic data
Age (y, mean  SEM) 67.3  5.2 65.3  5.6
Sex (no. female) 1 (25.0%) 1 (25.0%)
Preoperative risk factors
Infective endocarditis (no.) 0 (0.0%) 0 (0.0%)
Aortic insufficiency (no.) 1 (25.0%) 1 (25.0%)
Aortic stenosis (no.) 3 (75.0%) 3 (75.0%)
Operative features
Bioprosthesis (no.) 3 (75.0%) 1 (25.0%)
Mechanical prosthesis (no.) 1 (25.0%) 3 (75.0%)
Aortic crossclamp time
(min, mean  SEM)
63.0  10.0 64.0  9.0
Cardiopulmonary bypass time
(min, mean  SEM)
82.2  4.6 83.2  3.6
392 The Journal of Thoracic and Cardiovascular SurgAVR more commonly received bioprosthetic valves; how-
ever, these factors did not affect paravalvular leak rates. Fur-
ther, observed aortic crossclamp and cardiopulmonary
bypass times were statistically shorter among patients under-
going nonpledgeted AVR.
This study has several limitations. The retrospective
design of this study introduces inherent bias. We were alsoVariable (n ¼ 412) (n ¼ 259) value
Sepsis (no.) 7 (1.7%) 5 (1.9%) >.99
Stroke (no.) 10 (2.4%) 5 (1.9%) .79
Perioperative myocardial
infarction (no.)
2 (0.5%) 0 (0.0%) .53
Reoperation for bleeding or
tamponade (no.)
12 (2.9%) 7 (2.7%) >.99
Atrial fibrillation (no.) 98 (23.8%) 76 (29.3%) .12
Heart block (no.) 8 (1.9%) 6 (2.3%) .79
Cardiac arrest (no.) 3 (0.7%) 4 (1.5%) .44
Gastrointestinal event (no.) 5 (1.2%) 6 (2.3%) .35
Pneumonia (no.) 13 (3.2%) 7 (2.7%) .82
Prolonged ventilation (no.) 26 (6.3%) 13 (5.0%) .61
Renal failure (no.) 14 (3.4%) 16 (6.2%) .12
Hemodialysis (new onset, no.) 4 (1.0%) 0 (0.0%) .30
Hospital stay (d, mean  SEM)
Total 8.2  0.4 10.5  1.1 .02
Postoperative 7.0  0.4 7.5  0.9 .58
Paravalvular leak (no.) 2 (0.5%) 3 (1.2%) .38
Reoperation for paravalvular
leak (no.)
0 (0.0%) 3 (1.2%) .06
Operative mortality (no.) 8 (1.9%) 6 (2.3%) .79
ery c February 2011
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included in the STS database. The low incidence of major
paravalvular leak and low operative mortality after AVR
operations limited our ability to apply meaningful statistical
modeling for either adjusted outcomes or survival analysis.
The confounding effects of numerous operating surgeons,
as well as changes in both cardiac anesthesia and postoper-
ative care with time, are difficult to assess in data analysis.
Finally, larger sample sizes might have increased the ability
to detect small differences during group comparisons.
Nevertheless, the equivalent outcomes in mortality, major
paravalvular leak rate, and need for aortic valve reoperation
between nonpledgeted and pledgeted AVRs, coupled with
statistically shorter aortic crossclamp and cardiopulmonary
bypass times in the nonpledgeted cohort, highlights the
important clinical contribution of this study to the cardiac
literature.
CONCLUSIONS
We conclude that a nonpledgeted suture technique offers
an equivalent alternative to the traditional use of pledgets
during open aortic valve replacement, with no increase in
major paravalvular leak rate. Use of a nonpledgeted suture
technique provides a time efficient and safe approach to
aortic valve replacement operations.The Journal of Thoracic and CaWe thank Curtis Klann and Judy Smith for their assistance with
the STS database search and data collection.
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